| AML | Acute Myeloid Leukemia |
| CML | Chronic Myeloid Leukemia |
| TKI | Tyrosine Kinase Inhibitors |
| CP | Chronic Phase |
| AP | Accelerated Phase |
| BC | Blast Crisis |
| AcK382 | Acetylation of p53 at lysine 382 |
| IC | Inhibitory Concentration |
| AML | Acute Myeloid Leukemia |
| CML | Chronic Myeloid Leukemia |
| TKI | Tyrosine Kinase Inhibitors |
| CP | Chronic Phase |
| AP | Accelerated Phase |
| BC | Blast Crisis |
| AcK382 | Acetylation of p53 at lysine 382 |
| IC | Inhibitory Concentration |